Antibiotic and Chemotherapy E-Book
Nonfiction, Health & Well Being, Medical, Ailments & Diseases, Infectious Diseases, General, Diseases
| Author: | Roger G. Finch, MB BS, FRCP, FRCP(Ed), FRCPath, FFPM, David Greenwood, BSc, PhD, DSc, FRCPath, Richard J. Whitley, MD, S. Ragnar Norrby, MD, PhD, FRCP | ISBN: | 9780702047657 |
| Publisher: | Elsevier Health Sciences | Publication: | November 30, 2010 |
| Imprint: | Saunders | Language: | English |
| Author: | Roger G. Finch, MB BS, FRCP, FRCP(Ed), FRCPath, FFPM, David Greenwood, BSc, PhD, DSc, FRCPath, Richard J. Whitley, MD, S. Ragnar Norrby, MD, PhD, FRCP |
| ISBN: | 9780702047657 |
| Publisher: | Elsevier Health Sciences |
| Publication: | November 30, 2010 |
| Imprint: | Saunders |
| Language: | English |
Well-respected and widely regarded as the most comprehensive text in the field, Antibiotic and Chemotherapy, 9th Edition by Drs. Finch, Greenwood, Whitley, and Norrby, provides globally relevant coverage of all types of antimicrobial agents used in human medicine, including all antiviral, antiprotozoan and anthelminthic agents. Comprehensively updated to include new FDA and EMEA regulations, this edition keeps you current with brand-new information about antiretroviral agents and HIV, superficial and mucocutaneous myscoses and systemic infections, management of the immunocompromised patient, treatment of antimicrobial resistance, plus coverage of new anti-sepsis agents and host/microbe modulators. Reference is easy thanks to a unique 3-part structure covering general aspects of treatment; reviews of every agent; and details of treatments of particular infections.
Offer the best possible care and information to your patients about the increasing problem of multi-drug resistance and the wide range of new antiviral therapies now available for the treatment of HIV and other viral infections.
- Stay current with 21 new chapters including the latest information on superficial and mucocutaneous mycoses, systemic infections, anti-retroviral agents, and HIV.
- Get fresh perspectives and insights thanks to 21 newly-authored and extensively re-written chapters.
- Easily access information thanks to a unique 3-part structure covering general aspects of treatment; reviews of every agent; and details of treatments of particular infections.
- Apply the latest treatments for anti-microbial organisms such as MRSA, and multi-drug resistant forms of TB, malaria and gonorrhea.
Keep up on the latest FDA and EMEA regulations.
Well-respected and widely regarded as the most comprehensive text in the field, Antibiotic and Chemotherapy, 9th Edition by Drs. Finch, Greenwood, Whitley, and Norrby, provides globally relevant coverage of all types of antimicrobial agents used in human medicine, including all antiviral, antiprotozoan and anthelminthic agents. Comprehensively updated to include new FDA and EMEA regulations, this edition keeps you current with brand-new information about antiretroviral agents and HIV, superficial and mucocutaneous myscoses and systemic infections, management of the immunocompromised patient, treatment of antimicrobial resistance, plus coverage of new anti-sepsis agents and host/microbe modulators. Reference is easy thanks to a unique 3-part structure covering general aspects of treatment; reviews of every agent; and details of treatments of particular infections.
Offer the best possible care and information to your patients about the increasing problem of multi-drug resistance and the wide range of new antiviral therapies now available for the treatment of HIV and other viral infections.
- Stay current with 21 new chapters including the latest information on superficial and mucocutaneous mycoses, systemic infections, anti-retroviral agents, and HIV.
- Get fresh perspectives and insights thanks to 21 newly-authored and extensively re-written chapters.
- Easily access information thanks to a unique 3-part structure covering general aspects of treatment; reviews of every agent; and details of treatments of particular infections.
- Apply the latest treatments for anti-microbial organisms such as MRSA, and multi-drug resistant forms of TB, malaria and gonorrhea.
Keep up on the latest FDA and EMEA regulations.
